Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06253884 · ClinicalTrials.gov registry record · NA
Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease
A NA study, sponsored by Indiana University.
- Not yet
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT06253884 is a NA study that has not yet begun recruiting, run by Indiana University. The registered enrollment target is 30 participants.
The verdict
NCT06253884, a NA study, has not yet begun recruiting, sponsored by Indiana University.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
This is a prospective pilot study to evaluate the safety, tolerability and technical feasibility of utilizing carbon dioxide for assessing coronary blood flow in subjects with coronary artery disease.
Interventions
- DEVICE RespirAct
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2027-01-10 |
| Est. Completion | 2027-12-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06253884
The ClinicalTrials.gov registry entry for NCT06253884 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which RespirAct is the first listed.
NCT06253884 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06253884 about?
NCT06253884 is a clinical study titled "Utilizing Carbon Dioxide for Assessing Coronary Blood Flow in Subjects With Coronary Artery Disease". This is a prospective pilot study to evaluate the safety, tolerability and technical feasibility of utilizing carbon dioxide for assessing coronary blood flow in subjects with coronary artery disease.
What is the current status of trial NCT06253884?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2027-01-10. Estimated completion is 2027-12-15.
What interventions are being tested in trial NCT06253884?
The interventions under investigation include: RespirAct (DEVICE).
Who is sponsoring clinical trial NCT06253884?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.